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ABSTRACT  
Rheumatoid arthritis (RA) is a systemic autoimmune disease, which affects about 0.33 to 2.65% of the population. In RA Synovium contain 
various type of immune cell. In which only one cell population cannot cause rheumatoid arthritis that requires more than one cell population. In 
normal condition, they act as a switch (active or inactive the cell signaling). It controls cell growth, proliferation or met astasizes. In an 
autoimmune disorder such as rheumatoid arthritis, the immune system mistakenly attacks and destroys the body's cells and tissues. Mostly 
cells are present in limited numbers in normal human synovium, but in rheumatoid arthritis and other inflammatory joint diseases, this 
population can expand to constitute 5-20% or more of all synovial cells. Recent investigations in a murine model have demonstrated that cells 
can have a critical role in the generation of inflammation within the joint. 
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Introduction:  
Rheumatoid arthritis (RA) is incurable aggressive 
autoimmune disorder symptoms generally included joint 
pain, swelling, stiffness, angiogenesis, and hyperplasia in 
affected joints [1]. It developed when their own immune 
system mistakenly attacks and destroys the body’s cells and 
tissues [2]. The continuously progression of the disease may 
lead to lose functionality, decrease living standard and 
increase mortality and morbidity [3]. RA pathogenesis 
including immune complex interaction between genetic and 
environmental factors, inducing the aberrant activation of 
innate and adaptative immune system  which cause the 
immune desregulation, auto antigen presentation with 
increasing the concentration and range of cytokines and 
chemokines lead to T and B cells activation [4]. The most 
known function of the innate immune system is the initial 
detection of microbial pathogens, primarily pathogens 
attacked with the surface or intracellular patterns 
recognition receptors of macrophages and dendritic cells. 
Thus they become activated, leading to the production of 
cytokines and chemokines. The deregulation of these events 
leads to synovitis, proliferation of synovial, cartilage and 
subchondral bone destruction appear in the affected joint. 
Effectors cells and molecules of the innate system are stored 
locally if pathogen cannot overcome alone than 
macrophages and DCs travel from local lymphoid tissue 
where processed antigens are recognized by 
histocompatibility complex molecule to the naive T cell. 
Thus the beginning of an adaptive response complete with 
lasting immunological memory. The anti-inflammatory 
mediator helps to clearance and destruction of the pathogen. 
In RA, It’s proving that the innate immune system is 
continuously activated, as evidenced by the continual 
expression of macrophage-derived mediators [5]. Some of the 
common comorbidities associated with extra-articular 
organs, including skin, eye, lung, gastrointestinal system and 
cardiovascular system [6]. In the first stages of RA, the 
cellular components of the synovial membrane begin to 
invade the cartilage. But in the second stage, the synovial 
membrane converted into inflammatory tissue and due to 
this conversion of the synovial membrane becomes ruptured 
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adjacent bone and cartilage. The site between pannus and 
cartilage is occurred due to various cells such as activated 
dendrite cell, T-cell, B-cells, macrophages and synovial 
fibroblasts that manifested matrix metalloproteinase’s [7].   
Epidemiology: 
Rheumatoid arthritis (RA) affects approximately 0.33 to 
2.65% of the population, exhibit differences between 
countries and studies [8, 9]. As compared to other 
autoimmune diseases, RA is mostly found in women than 
men, this is due to hormonal differences [10]. RA is also 
largely occurred in the elderly patient with an immune 
system aging plays an important role in this disease [11, 12]. In 
case of RA, the patient mostly suffers from at least one or 
more comorbid conditions [13] and other commonly 
associated symptoms and diseases when you have arthritis. 
Some of the common comorbidities associated with RD are 
osteoporosis, anemia, bacterial infection, heart failure 
lymphoma, myocardial infarction, stroke, hypothyroidism, 
depression, gastrointestinal ulceration, fracture, and skin 
cancer [14].  
Table 1: Various co-morbidities and total Percentage [14, 15].  
Co morbidities Total percentage 
Total co morbidities 45 
Hypertension  24.3 
Hypothyroidism  16.9 
Diabetes mellitus  15.4 
Interstitial lung disease  1.4 
CAD  0.8 
TB  0.6 
Asthma  0.8 
CKD  0.6 
Nephritis  0.5 
CNS involvement 0.3 
Dyslipidemia 0.2 
APD  0.1 
Thalassemia  0.1 
Nodular sclerosis of eye  0.1 
 
Cell Biology of arthritis:  
 In RA Synovium contain various type of immune cell which 
are listed in table 1. In which only one cell population cannot 
cause rheumatoid arthritis that requires more than one cell 
population. Interaction between cell population in 
rheumatoid arthritis synovium can be divided into two 
classes: In the first class, interaction are mediated by 
secreted molecule such as cytokines and In the second type, 
cell-cell interaction requires direct contact between two 
different types of cell, which are listed into table 2 [16-17]. 
Table 2: Cellular components of synovial joint 
 Highly Abundant cell populations 
Fibroblastic (type B) synoviocytes 
Macrophage-like (type A) synoviocytes 
T lymphocytes 
 
Other cell populations 
Mast cells 
Dendritic cells 
B lymphocytes 
Plasma cells 
Osteoclasts 
 
Table 3: Cell-cell interaction that cause rheumatoid arthritis 
Macrophage–fibroblast 
B cell–fibroblast 
T cell–antigen-presenting cell 
T cell–fibroblast 
Leukocyte–endothelial 
 
The immune system and defense cell originate from the 
myeloid and lymphoid progenitor, this myeloid progenitor 
[Granulocytes, Monocytes (dendrites, macrophages, and 
mast cell)] and lymphoid progenitor [NK, T- cell and plasma 
cell] are the cell that crust up themselves and developed the 
cell-mediated immunity and also antibodies mediated of our 
body. In normal conditions, they activate or inactivate cell 
signaling as a switch. It controls the cellular pathway such as 
their growth, proliferation or metastasis [18]. In an 
autoimmune disorder such as rheumatoid arthritis, our 
immune system mistakenly attack and destroy the joint cells 
and tissues. These early auto antibodies are thought to first 
develop outside of the joints, environmental factor or other 
factors can modify our self-proteins making them targets for 
immune system one particular modification is called citral 
ination when the immune system recognizes these modified 
self-proteins it lead to a breach of self-tolerance and the 
production of autoreactive cells and autoantibodies [6, 19].  
Individual role of immune cell for development of 
arthritis:   
A)  Dendrite cell:  
Basic Biology: Dendrite cell is a granulocytic type of 
antigen-presenting immune cell that appears as a star. Their 
name is dendritic cell because of their long branches which 
are very similar to that of the dendrite of a neuron that’s 
why their name is a dendritic cell. It is originated either from 
lymphoid progenitor or from the myeloid progenitor. Most 
of the dendritic cells occur in the tissues of the external site, 
such as skin, nose, lung and digestive tract [20, 21].  
Function: 
Dendritic cells play a very important role in the initiation of 
the immune response. They also create a bridge between 
innate and adaptive immunity [22]. Dendritic cells (DCs) are 
the most important antigen-presenting cells and they also 
maintain the immune homeostasis in the body. DCs (mDCs) 
mature cell are immunogenic. They can detect the antigen 
and bind them on their surface, and initiate the immune-
related responses [23]. It is also able to present to T cell 
antigenic peptides in the concern of the MHC-II [24]. While in 
immature DCs (imDCs) have weak antigen-presenting then 
mature DCs and T cell activating abilities, hence they may 
induce T cell tolerance [25, 26]. It is thought that the tolerance 
potential of the dendritic cell is to release the 
immunosuppressive Cytokines such as TGF-β and IL-10 and 
also they having surface programmed death legends like PD-
L1 and PD-L2 [27].  
Dendrite cell in RA 
CD4 T cell activation by DCs: Dendritic cells (DCs) are a 
major regulator of adaptive immune responses. Initially, CD4 
T cells bind with synovial DCs; as a result, T cell activates. 
After activation of CD4 T cells, antigen-MHC-II complexes are 
formed on the surface of the APC and initiate co-stimulatory 
signals [28].  During continuously binding with APCs surface, 
CTLA-4 will fight with CD28 for CD80/CD86, and after 
competition of CTLA- 4 inhibition of T cell activation. T- Cell 
interact with other cell and involve in bone erosion, CTLA- 4 
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is the major site for drug therapy in case of rheumatoid 
arthritis [29].  
B)  T- CELL:  
Basic Biology: T-cells are also known as lymphocytic cells 
generated from bone marrow and mature in the thymus 
gland and play a major role in immune response in our body. 
They are mostly divided into T- helper cell and T- NK cells. T 
cell is showed the dynamic shape and also having about 8-10 
micron in diameter. T cell possesses a large nucleus and 
contains few mitochondria, ribosomes, and lysosomes. The 
cytoplasmic component is larger when antigens are attached 
to the cell [30, 31]. 
Function: The main function of T-cell is to produced cell-
mediated immune response various type of cell-cell 
interaction occurs between the t-cells and another cell, for 
example, the interaction between a macrophage and a T cell 
for a phagocytic response, the interaction between T cell and 
B cell for humoral response and interaction between a T cell 
and another T cell which release IL2, IL4, IL5, interferon-
gamma, macrophages inhibitor factor, and macrophage 
activation factors this are very important cytokines and they 
play a very important role within the immune system. Hence 
T cell can arise two types of functions one in which is 
effecter function and another one is regulating function. 
They expressed CD4, CD8, CD44, CD25 receptor. The T cell 
receptor consists of the protein complex and actually, they 
are comprised of two separate peptide chains [32, 33].  CD4 T- 
Cell could play an important role in the development of the 
chronic inflammation occurring in RA. These cells are a 
major regulator of the immune response producing pro-
inflammatory cytokine and operating with B- Cells for 
secreting antibodies CACPA or rheumatoid factor, while not 
in the other patient [34]. 
CD4 T cell in rheumatoid arthritis: 
CD4 T cell activation and function in synovitis: CD4 T-Cell 
is expending in overall synovium, where they establish 
communication between cell to cell and play a vital role in 
the pathological immune response to joint damage [35].
  
 
 
Regulation of FLSs by CD4 T cells: 
FLSs play a critical role in joint architecture. In a normal 
joint, this is the component that forms synovial lining and 
secretes synovial fluid. FLSs are an aggressive phenotype in 
RA, which causes hyperplasia in synovitis. This hyperplasia 
in synovitis creates a hypoxic environment where 
angiogenesis and elevation of inflammation is developed. 
Also, Rheumatic arthritis FLSs secreted large amounts of 
collagen proteases in synovial fluid, as a result of bone 
erosion, cartilage destruction, and trigger pro-inflammatory 
cytokines. The regulation of FLSs is altered by CD4 T cells by 
the help of pro-inflammatory cytokines TNF-α, IL-15, and IL-
18 [36]. FLSs Collagen synthesis also altered by CD4 T cells, 
this process is carried out by TNF-α, IFN-γ, and IL-1α [37].  
 
 
Regulation of macrophages/monocytes by CD4 T cells: 
Macrophages cells are the most abundant monocyte in the 
synovial joint. Where they directly interact with synovial 
cells and secrete pro-inflammatory mediators like TNF-α 
cytokine. CD4 T- Cells also regulate macrophage-like 
synoviocytes. T- Cell having homologous behavior in RA 
patients [38]. Where TNF-α is also produced by IL15 
stimulated NK Cell [39]. Neutralizing therapy used for 
minimizing the TNF-α in the progression of RA [40]. 
Macrophages are progenitors of osteoclasts that degraded 
bone in the case of RA. In normal conditions, osteoclast and 
osteoclast maintain the homeostasis and skeletal integrity [41, 
42].  
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C) Mast Cell  
Basic Biology: Mast cells are present in mucosae and 
Connective tissue, normally aggregated at blood vessels, 
around nerves and epithelial surfaces [43]. They are 
originated from bone marrow and known as CD34+ 
progenitor cells after entered inside the tissue they are 
known as mature mast cells [44, 45]. Which are intensely 
heterogeneous, and largely variable in cytokine production, 
granule contents, and receptor expression. The major role of 
mast cell has antigen presentation, intracellular killing, and 
phagocytosis, [46, 47]. They are found in blood vessels, synovial 
cavity peritoneum, and pleural space. This existence 
indicates as a guard for detecting antigens and inflammatory 
response [48]. Thereafter, mast cells clustered in chronically 
inflamed cartilage tissue. 
Function of Mast cell: 
IgE-Activation: Mast cells are having high-affinity toward 
IgE receptor FcεR1, The receptor is tetrameric structure 
made up of α, β and 2γ subunit [49]. When the FcεR1 receptor 
bind with antigen, the immunoreceptor tyrosine-based 
activation motifs (ITAMs) are phosphorylated on the β and γ 
chain subunit and this turn activates a signaling cascade, as a 
result, three distinct pathways are initiated de novo synthesis 
of cytokines, eicosanoids pathway, and chemokines pathway. 
Within second to minute the granules present in the 
cytoplasm of the mast cell are ruptured to each other and 
release from intracellular to extracellular spaces due to the 
IgE cross-linking. The granules are released on the basis 
matured mast cell, the chemical mediator of mast cell such as 
histamine, neutral proteases, and heparin, broadly divided 
into three group carboxypeptidases, chymases, and 
tryptases. Histamine enhances vascular permeability; 
proteoglycans provide a stage where granules of proteases 
are packaging and the neutral proteases are rupture proteins 
from complex and plasma therewith to activating 
propeptides interleukin-1β and angiotensin II [50]. Tumor 
necrosis factor (TNF) is also stored in the granules which are 
used for the development of airway hyperreactivity (AHR) 
[51]. The activation of the IgE receptor which turns initiates 
the arachidonic acid pathway and produces eicosanoids [52]. 
 
Table 4: Selected mediators of mast cell and their roles in arthritis: 
Mediator Some relevant functions 
Histamine Leukocyte recruitment, Vascular permeability, fibroblast activation 
Heparin Angiogenesis and osteoclast  activation 
Neutral proteases Matrix degradation, leukocyte recruitment, fibroblast activation 
TNF Leukocyte recruitment, fibroblast activation 
PGD2 Vascular permeability, Neutrophils recruitment 
LTB4 Vascular permeability, leukocyte activation 
Cysteinyl 
leukotrienes 
Vascular permeability, immunomodulatory (LTC4) 
IL-1 Leukocyte recruitment, fibroblast, angiogenesis differentiation and activation 
IL-2 Lymphocyte stimulation 
IL-3 Leukocyte growth factor 
IL-4 Immunomodulatory, profibrotic 
IL-6 leukocytes and fibroblasts activation 
IL-8 Neutrophil recruitment 
IL-10 Immunomodulatory 
IL-13 Immunomodulatory, B cell stimulation 
IL-18 Angiogenesis, lymphocyte stimulation 
TNF Leukocyte recruitment, fibroblast/chondrocyte activation, angiogenesis 
IFN-γ Activation of synovial macrophages 
TGF-β Immunomodulatory, fibroblast mitogen, angiogenesis 
PDGF Fibroblast mitogen 
VEGF Fibroblast mitogen, angiogenesis 
Bfgf Fibroblast mitogen 
NGF Fibroblast mitogen 
MCP-1 Leukocyte recruitment 
MIP-1α, MIP-1β Leukocyte recruitment, osteoclast differentiation 
RANTES Leukocyte recruitment 
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Mast cells in inflammatory arthritis:  
Rheumatic arthritis (RA) is a synovial inflamed tissue in 
which the amount of mast cells is increased in the synovial 
joint (Fig. 2). In the normal condition, the synovium joint 
made up of a thin layer of macrophages (‘Type A’ cells) and 
fibroblasts (‘Type B’ cells) which are enclosed in the sub-
lining of highly vascular matrix connective tissue and 
adipose tissue. In the normal condition, mast cell is found 
around the vessels and nerve as a clustered form and 
covering up to 3% of all cells inside the synovium [53]. In 
normal condition; mast cell remains a defense system 
against bacterial peritonitis infection. In the case of RA 
patient, the synovial lining is expended from 1–4 cells to 10 
cells and the T cells, B cells, macrophages, and neutrophils 
are infiltrated with sub lining. The number of clustered mast 
cells depends upon the patient [54, 55, 56]. Mast cells are 
present around the synovial sub-lining, where they have 
formed a cluster in an abnormal layer of pannus which is 
present near joint cartilage and begins bone erosion [57]. The 
phagocytosis nature of mast cells may also play critical roles 
for the stimulation of inflammatory mediators due to the 
profibrotic effects of IL-4 and T and B lymphocytes 
stimulation by IL-6 [58].  
 
                 
                         IL 1, IL6, BFGF                                                   Proteases collageneses 
Mast cell                                           Fibroblast activation                                                      Cartilage distruction       
                            PDGF                        and Hyperplasia                       MMPs                                   (Pannus) 
 
 
                            IFN-ᵞ IL6 
Mast cell                                                    Macrophages   Activation   (Synovial linning) 
                                                           
 
                                       TNF, MCP 6,  
Mast cell                                                                  Leukocyte Recruitment and activation 
                          Chemokine, leukodrine     
 
 
                             Heparin, MIP-1α 
Mast cell                                                                 Osteoclast differentiation and activation 
                                TNF, IL1                         
 
 
                                TNF, IL1, Histamine 
Mast cell                                                                   Endothelium (Increase Adhesion molecule, Permeability,  Angiogenesis)                              
                                   Leukotrines                                    
   
 
Fig 2: - Cell mediator and Cell-Cell interaction of mast cell in rheumatoid arthritis of synovitis including Synovial Osteoclast, 
Synovial fibroblast, and macrophages recruitment and activation causes cartilage and bone destruction. Once mast cell is 
enhancing in synovitis they lead to increase vascular permeability, molecular interaction, and angiogenesis. Mast cells may 
cause cartilage and bone destruction by matrix metalloproteinases (MMPs) through fibroblasts and chondrocytes in the pannus 
site and lead to direct and indirect differentiation and activation of osteoclast.  
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D)  Synovial Fibroblast:  
Basic Biology: Fibroblast cells are mostly found in the 
connective tissue which connects, binds and supports other 
tissues and organs. These cells derived from mesenchymal 
stem cells, stem cells that are adequate for differentiation as 
they are needed. Fibroblast is usually 10-15 micron in size. 
The lifetime of fibroblast is about 57 days measured in chick 
embryos. Fibroblast cells use endocytosis as their transport 
mechanism. They play a major role in the propagation of 
inflammation and bone erosion [59]. In normal condition, 
synovial tissue comprises two layers the first one is the 
intima layer or synovial lining and the second one is an 
underlying layer or subintima layer. The first one is directly 
attached to the intra-articular cavity which is present inside 
the joint capsule and this synovial cavity is filled with 
synovial fluid. The main job of the intima is to secret the 
components of the synovial fluid are within this intima and 
this layer is about  20–40 Am thick, one to three cells deep, 
loosely organized, avascular, and not supported by a 
basement membrane. The lower layer is known as the 
subintima of the synovial membrane [60]. In the normal 
intima and subintima, two types of cells face into the synovial 
fluid, first one is known as macrophage-like (type A) 
synoviocytes (MLS) [61,62], and the second one is FLS (type B 
synoviocytes). FLS membrane is bipolar, spindle-shaped cells 
with prominent secretary hyaluronic acid machinery, 
including endoplasmic reticulum, higher ribosomal arrays, 
and well-developed Golgi apparatus. Their nuclei are pale. In 
contrast to FLS, MLS and lack HLA class II antigens, having 
endocytosis ability, and are CD68 negative [63]. 
FLS Function: The major function of Fibroblastic-like 
synovial cells (FLS) is to maintain the structural and 
functional integrity of the connective tissue by continuously 
releasing extracellular proteins like collagen, glycoproteins, 
and glycosaminoglycans. Fibroblast cells maintain 
homeostasis by keeping a normal pH 7.4-7.7. FLS plays a 
critical role in normal joint homeostasis. The Mature intimal 
FLS produces an increasing amount of long-chain polymeric 
hyaluronan into the synovial cavity, which has provided 
lubricating and immunomodulatory properties. Intimal FLSs 
also secrete the glycoprotein lubricin, as well as plasminogen 
activator. Lubricin imparts viscosity at synovial space. 
Plasminogen activator may inhibit fibrous adhesions in the 
joint, promoting joint bone movement [64]. The major job of 
FLS is to control synovial fluid volume. When synovial fluid 
volumes are increased due to mechanical stress on intimal 
FLS appeared, lowering hyaluronan production leads to 
decreasing oncotic pressure in the joint. In contrast, joint 
destruction in arthritis represents due to disturbance of 
synovial fluid volume control, with friction forces provoking 
excess hyaluronan production, and accumulation of plasma 
dialysate in the synovial cavity. FLS may also involve in 
inflammatory responses as well as its co-receptor CD97, DAF 
modulates tissue responses can also alter on the cell surface 
[65].  FLS also involve in leukocyte trafficking, via their 
interaction with leukocytes. Intimal FLS act as a ligand like 
and VCAM-1 CD44, ICAM-1 and integrins, this ligand bind 
with other cells. Thus, intimal FLS may inhibit mononuclear 
cells such as monocytes and lymphocytic cells in the 
synovium while entering neutrophil into the joint space, 
through which the amount of leukocyte is controlled via two 
compartments while the amount of leukocyte is to be 
reduced in the synovial cavity. Finally, we can say that FLS 
maintains the maintenance of joint capsules in case of the 
joint disorder [66].  
The FLS in RA 
Hyperproliferation of FLS: RA FLS are hyperproliferative 
[67], and several in vitro studies, it has been finding that the 
rheumatoid arthritis FLS makes more division than normal 
cell [68]. In the rheumatoid arthritis condition several growth 
factors which overexpress the FLS mitosis in the synovial 
joint [69].                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
Inflammation and autoimmunity: When FLS are activated 
they them self produce inflammatory mediators including 
IL1, IIL4, IL6, IL8, IL10, IL12, IL13, IL17, IL18, IL21, TNF-a, 
TGF-h, and cyclooxygenase-2, prostaglandin E2 [70, 71]. IL15 is 
a pro-inflammatory cytokine, which also activates t-cell, 
neutrophils and macrophages. In the case of a rheumatoid 
arthritis patient, this cell is overexpressed by FLS [72]. 
Therefore, FLS is the most important driver in rheumatoid 
arthritis inflammation. RA FLS also secret several types of 
proangiogenic factor including FGF [73], VEGF [74], and IL-18 
[75], it is also involved in blood vessels growth, require 
arthritis process and pannus formative. Angiopoietins are 
responsible for inflammation in rheumatoid arthritis with 
the help of angiogenesis and leukocyte [76, 77] production, 
direct contact between T cells and RA FLS leading to T cell 
activation, enhancing the production of cytokines as well as T 
cell proliferation [78, 79, 80]. Thus, Rheumatoid arthritis FLS 
may play a major role in multiplication, inflammation, and 
autoimmunity. Conversely, resting FLS activated by T cells 
[81].  
FLS and tissue destruction: Fibroblast-Like Synoviocyte 
(FLS) produced an HK2 enzyme that is very important for 
tissue destruction in rheumatoid arthritis. They also produce 
matrix metalloproteases which responsible for cartilage 
destruction.  This is commonly observed in tandem, 
laboratory and clinical evidence suggests that these 
processes are distinct [82, 83]. Radiographic joint damage 
evaluated in RA is joint space destruction, enlargement of 
synovial lining cell, pannus formation, marginal cartilage 
erosions, and bone erosions. 
 
                                               IL 6 
Fibroblast                                                          Macrophages  
                                    chemokines 
 
                               Protease collagens 
Fibroblast                                                          Chondrocytes    
                                  IFN- β, MHC- 2 
                
                                  CXCL 12, CCL21      
 Fibroblast                                                        T lymphocyte recruitment and retention 
                                    
                                       VLA- 4 
Fibroblast                                                         B- lymphocyte                        
                               CXCL 13, CXCL 12 
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Fig 3: Cellular components and cell-cell interaction of Fibroblasts like cell in proinflammatory function and rheumatoid arthritis 
in synovitis. Synovial fibroblast cell interacts with different cell including macrophages, T- lymphocyte, B- lymphocyte and 
other in the presence of soluble factors like IL6, IFN- β, MHC 2, CXCL- 12, CXCL 13, CCL21, VLA-4 to maintain synovial lining by 
their recruitment, retention, activation, and differentiation.  
 
E)  Synovial Macrophages: 
Basic Biology: A macrophage is a granulocyte of white 
blood cell (WBC), which performs the process of 
phagocytosis. A macrophage is a cell generated from the 
monocyte progenitor and release in blood. They are found in 
different tissue according to their performance such as in the 
liver they are called kuffer cells, in lung alveolar macrophage 
cell and in joint it is known as synovial macrophages. The 
size of macrophages is about 15-18 µm in diameter [84, 85].  
MLS Function: Macrophages are caused by inflammation 
and elevate the body temperature while pathogens entered 
in our body. It acts as a messenger for the hypothalamus to 
increase body temperature. Macrophages are phagocytic [86]. 
There is two pathogen killing mechanism first one is oxygen 
dependent and second one is oxygen-independent. In 
oxygen-dependent, they produce ROS and RNS, which is 
causing damage to the pathogen and another one is an 
oxygen-independent mechanism that firstly engulfs the 
bacteria and digests them through a lysosomal antimicrobial 
peptide, after digestion, they removed from the body [87]. 
Macrophages have secreted some molecule like cytokine, 
IL1, which are inflammation producing molecule this 
molecule alarm other macrophages around the body and 
other immune cells come and fight the pathogen [88].  
The MLS in RA: The type A (the macrophage) interlocked 
with the type B cell (the fibroblast) in the synovial joint. In 
the normal condition, the type B-cell is found largely in 
synovium as compared to Type A-cell, while in RA condition 
type A-cell will be found greatly [89]. They also involved in 
bone resorption [90]. Rheumatoid arthritis most common 
caused by macrophages. When the number of macrophages 
is increased in synovium they cause radiological damage [91], 
joint pain and inflammation [92]. Synovitis degeneration with 
rheumatoid arthritis can be seen in almost 50% of the 
patient without cellular congestion. Chemical mediator 
which responsible for macrophages activation in rheumatoid 
arthritis-like growth factors and cytokines, including TNF-a, 
GM-CSF,  IL-1, 6, 8, 10, 13, 15, 18, migration inhibitory factor 
(MIF) and chemokines [93, 94]. Macrophages are produced 
several types of proteases including leukocyte elastase, 
MMP-1, MMP-3 and MMP-9, and matrix metalloproteinases 
(MMPs) in case of articular destruction [95]. 
 
 
                                        TNF, IL-1                                                                   Protease collagenes 
Macrophages                                                  Fibroblast activation                                                             MMPs and cathepsin 
 
                                                                                                                                 
                                                                                                                                                 RANKL            
Macrophages                                                    T lymphocyte activation                                                        Osteoclast 
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Fig 4:- Synovial lining consists of both activated macrophages and fibroblastic synoviocytes, which actively degraded cartilage 
and bone by producing protease collagens, RANKL, TNF, and IL-1 of which formed MMPs, cathepsin, and osteoclast which 
responsible for bone erosion.  
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